Signaling Pathways - Selective - Topoisomerases - Androgen Receptors
清除全部
-
B2295 Pirarubicin1 Citation中文名: 吡柔比星Target: TopoisomerasesSummary: 拓扑异构酶II抑制剂，蒽环类抗生素 -
B2293 Irinotecan HCl Trihydrate中文名: 盐酸依立替康三水合物Target: TopoisomerasesSummary: 拓扑异构酶I抑制剂 -
B2290 Beta-Lapachone中文名: β-拉帕醌Target: TopoisomerasesSummary: 选择性DNA拓扑异构酶I抑制剂 -
A8623 TOK-001中文名: 加来特龙,伽来特隆Target: Androgen Receptors|Cytochrome P450 (CYP450)Summary: CYP17抑制剂和雄激素受体（AR）拮抗剂 -
A8400 Clinafloxacin CI96 AM1091中文名: 克林沙星Target: TopoisomerasesSummary: 拓扑异构酶抑制剂 -
A2150 AndarineTarget: Androgen ReceptorsSummary: 雄激素受体拮抗剂 -
A2451 Epirubicin HCl中文名: 盐酸表阿霉素Target: TopoisomerasesSummary: 抗生素类抗肿瘤药物 -
A5065 Bicalutamide1 Citation中文名: 比卡鲁胺Target: Androgen ReceptorsSummary: 雄激素受体（Androgen receptor）拮抗剂 -
A1971 Etoposide4 Citation中文名: 依托泊苷Target: TopoisomerasesSummary: 拓扑异构酶II（Topo II）抑制剂 -
A1832 Doxorubicin (Adriamycin) HCl2 Citation中文名: 盐酸多柔比星，盐酸阿霉素Target: TopoisomerasesSummary: 抗肿瘤抗生素，抑制TOPO II。